| |
Records |
Links |
|
Author |
Observatoire européen des drogues et des toxicomanies |
|
| |
Title |
Rapport annuel 2011 : état du phénomène de la drogue en Europe |
Type  |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
117 |
|
| |
Keywords |
AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; mephedrone; Europe; annual report |
|
| |
Abstract |
The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office des publications de l'Union européenne |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Rapport annuel |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1609-6142 |
ISBN |
978-92-9168-474-8 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Auch auf Deutsch vorhanden: 50-12171; anche disponibile in italiano: 50-12173; also available in English: 50-12174 |
Approved |
no |
|
| |
Call Number |
50-12172 |
Serial |
50908 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Osservatorio europeo delle droghe e delle tossicodipendenze |
|
| |
Title |
Relazione annuale 2011 : evoluzione del fenomeno della droga in Europa |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
115 |
|
| |
Keywords |
AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; communicable disease; AODR mortality; prevalence; Europe; annual report |
|
| |
Abstract |
The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Ufficio delle pubblicazioni dellUnione europea |
Place of Publication |
Lussemburgo |
Editor |
|
|
| |
Language |
Italian |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Relazione annuale |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1609-6169 |
ISBN |
978-92-9168-476-2 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Auch auf Deutsch vorhanden: 50-12171; anche disponibile in italiano: 50-12172; also available in English: 50-12173 |
Approved |
no |
|
| |
Call Number |
50-12173 |
Serial |
50909 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Annual report 2011 : the state of the drugs problem in Europe |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
105 |
|
| |
Keywords |
AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; mephedrone; Europe; annual report |
|
| |
Abstract |
The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Annual report |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1609-6150 |
ISBN |
978-92-9168-470-0 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
Auch auf Deutsch vorhanden: 50-12171; aussi disponible en français: 50-12172; anche disponibile in italiano: 50-12173 |
Approved |
no |
|
| |
Call Number |
50-12174 |
Serial |
50910 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Cost and financing of drug treatment services in Europe : an exploratory study |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
23 |
|
| |
Keywords |
Aod; AOD use, abuse, and dependence; addiction; heroin; treatment and maintenance; detoxification; inpatient care; outpatient care; methadone; heroin-assisted treatment; financial management; treatment cost; treatment method; financial statement; financing; study; Europe; report |
|
| |
Abstract |
Recent estimates suggest that, each year, over 1 million Europeans receive treatment for problems related to the use of illicit drugs (EMCDDA, 2010). Of these, more than half receive opioid substitution treatment for problems related to opioid drugs, primarily heroin. The current levels of provision of drug treatment services in the European Union are the result of an expansion of services that has taken place during the last two decades. For much of that time, services expanded against a background of a growing drug problem, and one in which economic conditions were largely favourable. Now, however, in an era of cuts in government expenditure, managing the costs of treatment and ensuring the highest quality and best outcomes for the lowest possible cost are priorities. While measuring and improving drug treatment outcomes have been relatively high on the research agenda in recent years, the cost of treatment has received far less research attention. Addressing this information gap is likely to have a number of benefi ts for both decision-makers and treatment providers. On the one hand, service providers need accurate information on the costs of service provision in order to plan the allocation of resources. On the other, decision-makers and funders can use such information as a means of cost control, for example, by comparing costs of similar services or those of alternative providers of similar services. Finally, as a part of a fuller economic analysis, information on service costs is needed to determine the cost-effectiveness of interventions and treatment programmes. The cost of drug treatment in Europe is looked at from two main angles in this Selected issue. First, it presents an overview of the main sources of drug treatment funding and the financing mechanisms that are employed in European countries. The available data are presented on who is paying for drug treatment, how funding is organised, and how funding is distributed among different treatment modalities. This is followed by an analysis of the unit costs of different types of drug treatment. Costs related to opioid substitution treatment including the costs of substitution medication for a number of European countries are presented here. This publication keeps a tight focus on the cost of drug treatment and does not attempt to undertake a broader economic analysis of the healthcare and social costs relating to illicit drugs. This Selected issue represents a fi rst attempt to provide a European overview of drug treatment costs, and individual countries are brought into focus to illustrate specifi c aspects of the analysis. This subject is both topical and methodologically challenging. The varying availability of information as well as the complexity of funding arrangements mean that, at best, only very incomplete estimates can be made of the costs of (or expenditure on) drug treatment in Europe. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Selected issues |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1830-7957 |
ISBN |
978-92-9168-464-9 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12180 |
Serial |
50911 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Mortality related to drug in Europe : public health implications |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
33 |
|
| |
Keywords |
Aod; AOD use, abuse, and dependence; addiction; illicit drug; heroin; morbidity; AOD overdose; AODR mortality; prevalence; Europe; report |
|
| |
Abstract |
In recent decades, the overall level of illicit drug use in Europe has risen dramatically, and with it the number of deaths among the drug-using population, in particular among problem drug users. In the 21st century, a considerable share of premature or avoidable mortality among young adults can be attributed to illicit drug overdose, which accounts for an estimated 4% of deaths among those aged 15–39 in Europe (1). These deaths are often related to injecting drug use and, in most cases, involve a combination of substances (Best et al., 2000), but they represent only part of mortality among drug users (2). In addition, a substantial number of deaths are indirectly related to drug use, such as those from HIV/AIDS related to injecting drug use, accidents, violence and suicides. The high levels of mortality among drug users are a serious cause for concern both at the individual and the societal level. The number of problem opioid users in Europe is cautiously estimated at about 1.3 million (3), and it is among these opioid users, particularly injectors, that we find the greatest share of morbidity and mortality related to illicit drug use in Europe. Heroin is the drug most often associated with overdose, although other drugs and alcohol are commonly present. Overdose represents a major cause of avoidable death associated with illicit drug use, and from 1990 to 2010, between 6 500 and 8 500 overdose deaths have |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12181 |
Serial |
50912 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Guidelines for the treatment of drug dependence: a European perspective |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
23 |
|
| |
Keywords |
Aod; AOD use, abuse, and dependence; drug; drug dependent; addiction; illicit drug; opioids in any form; heroin; evaluation; treatment and maintenance; treatment and patient care; Europe; report |
|
| |
Abstract |
The last two decades have witnessed an increase in the development of treatment guidelines in the European drugs field. This has largely built on a body of evidence on the treatment of drug dependence that has developed since the 1980s, alongside a growing interest in, and understanding of, the eff ectiveness of interventions. A range of tools became available to translate evidence into satisfactory and sustainable results, among them : guidelines and standards, education and training, implementation and assessment, monitoring, and accreditation systems based on quality standards. The focus of this Selected issue is drug dependence treatment guidelines – one of the main measures used to improve and guarantee the quality of drug treatment provision. The focus on drug dependence treatment is timely and appropriate, as current estimates suggest that at least 1.1 million people were treated for illicit drug use in the European Union, Croatia, Turkey and Norway during 2009 (1). This is the consequence of a major expansion of specialised outpatient services during the last twenty years, with the significant inclusion of primary healthcare, self-help groups, general mental health services, and outreach and low-threshold service providers. While more than half of clients received opioid substitution treatment, a substantial number received other forms of treatment for problems related to opioids, stimulants, cannabis and other illicit drugs. The main modalities used for the treatment of drug problems in Europe are opioid substitution, detoxification and psychosocial interventions. Drug dependence treatment services are provided in a variety of settings: specialised treatment units (including outpatient and inpatient centres), mental health clinics and hospitals, units in prison, lowthreshold agencies and by offi ce-based general practitioners. Particularly in western Europe, there appears to have been a gradual shift away from a view of drug dependence treatment as the responsibility of a few specialist disciplines providing intensive, short-term interventions towards a multidisciplinary, integrated and longer-term approach. Evidence suggests that continuous care and integrated treatment responses may be aided by the development and use of guidelines, care protocols and case management by all the relevant service providers (Haggerty et al., 2003). This publication sets out to introduce the topic of treatment quality improvement by the development of guidelines (and other documents), and to provide an overview of the existing national guidelines for the treatment of drug dependence in Europe. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12182 |
Serial |
50913 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Beratungsstelle für Suchtfragen Appenzell Ausserrhoden |
|
| |
Title |
Tätigkeitsbericht 2011 |
Type |
Report |
| |
Year |
2012 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
8 |
|
| |
Keywords |
social services; annual report; Appenzell Ausserrhoden |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Kanton Appenzell Ausserrhoden, Departement Gesundheit, Beratungsstelle für Suchtfragen Appenzell Ausserrhoden |
Place of Publication |
Bühler |
Editor |
|
|
| |
Language |
German |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12187 |
Serial |
50914 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Cagliero, Suzanne; Lagrange, Hugues |
|
| |
Title |
La consommation de drogues dans le milieu de la prostitution féminine |
Type |
Report |
| |
Year |
2004 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
91 |
|
| |
Keywords |
AOD consumption; AOD dependence; prostitution; tobacco product; cannabis; cocaine; gender; woman; research; report; France |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Observatoire français des drogues et des toxicomanies (OFDT) |
Place of Publication |
Saint-Denis-La Plaine |
Editor |
Observatoire français des drogues et des toxicomanies |
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12189 |
Serial |
50915 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Laurindo da Silva, Lindinalva; Evangelista, Luizmar |
|
| |
Title |
La consommation de drogues dans le milieu de la prostitution masculine |
Type |
Report |
| |
Year |
2004 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
147 |
|
| |
Keywords |
AOD consumption; AOD dependence; prostitution; tobacco product; cannabis; cocaine; gender; man; research; report; France |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Observatoire français des drogues et des toxicomanies (OFDT) |
Place of Publication |
Saint-Denis-La Plaine |
Editor |
Observatoire français des drogues et des toxicomanies |
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12190 |
Serial |
50916 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Maguet, Olivier; Caldéron, Christine |
|
| |
Title |
Insertion par l'emploi des usagers de drogues : territoires en réseaux |
Type |
Report |
| |
Year |
2009 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
31 |
|
| |
Keywords |
AOD use, abuse, and dependence; addiction; France; Europe |
|
| |
Abstract |
Les addictions sont souvent associées à la précarité, à l’errance et à l’absence de travail. Le plan gouvernemental a voulu agir sur les facteurs pouvant concourir à l’insertion ou la réinsertion sociale des personnes présentant une addiction, notamment par l’établissement de bonnes pratiques destinées aux professionnels de l’addiction et aux intervenants auprès de publics précaires. Une première étape de cette action, portée par l’association “Drogues et Société”, a abouti à l’élaboration du document intitulé “Insertion par l’emploi des usagers de drogues”. Cet ouvrage, réalisé également avec le soutien du Fond Social Européen, présente des pistes de réflexion à partir d’actions et de réponses existantes. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Commission européenne |
Place of Publication |
Lyon |
Editor |
Commission européenne |
|
| |
Language |
French |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
|
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12207 |
Serial |
50917 |
|
| Permanent link to this record |
